Clinical Trials · NCT02770391
Apalutamide and Leuprolide in Intermediate and High-risk Prostate Cancer
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- Case Comprehensive Cancer Center
- Enrollment
- 54
- Start date
- Oct 2016
- Locations
- 1 site, United States
- Primary endpoint
- Dihydrotestosterone (DHT) Concentration in Benign Prostate Tissue After a Combination Drug Treatment Based on Genotype Status